Directorate Change

Hargreaves Lansdown PLC
06 February 2024
 

HARGREAVES LANSDOWN PLC (HL):  CHAIR SUCCESSION

 

06 February 2024

 

Further to its announcement on 29 November 2023 and following regulatory approval of  Alison Platt, the Board of HL is pleased to announce her appointment to role of Chair of the Board and as a Non-Executive Director of HL with effect from today, Tuesday 06 February 2024.

 

 

Other than the directorships disclosed above, there are no matters required by paragraphs LR 9.6.13R (1) to (6) of the listing rules to be disclosed.

 

 

 For further information please contact:

Hargreaves Lansdown

Brunswick

James Found, Investor Relations

07970 066 634

Nick Cosgrove

+44(0)207 404 5959

Danny Cox, Media Relations

07989 672 071


 

 

BIOGRAPHY

 

Alison Platt

Alison has extensive leadership experience across both private and listed companies in the healthcare, financial services, retail and property, and regulated sectors. She currently holds Chair positions at Dechra Pharmaceuticals, a FTSE100 specialist veterinary products business, and insurance company Ageas UK. She has also been a Non-Executive Director of Tesco Plc since 2016.

 

Alison was CEO of Countrywide from 2014 - 2018 and prior to that she held several senior roles at BUPA, including as Managing Director of its International Development Markets business.  She was previously a Non-executive director of the Foreign and Commonwealth Office, a member of Hampton-Alexander review steering group advising on diversity and inclusion and Chair of Opportunity Now.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings